Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best …
DP McLornan, JC Hernandez-Boluda, T Czerw… - Leukemia, 2021 - nature.com
Allogeneic haematopoietic cell transplantation (allo-HCT) remains the only curative
approach in myelofibrosis (MF). Despite advances over recent decades, relapse and non …
approach in myelofibrosis (MF). Despite advances over recent decades, relapse and non …
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group
NM Kröger, JH Deeg, E Olavarria, D Niederwieser… - Leukemia, 2015 - nature.com
The aim of this work is to produce recommendations on the management of allogeneic stem
cell transplantation (allo-SCT) in primary myelofibrosis (PMF). A comprehensive systematic …
cell transplantation (allo-SCT) in primary myelofibrosis (PMF). A comprehensive systematic …
Survival following allogeneic transplant in patients with myelofibrosis
Allogeneic hematopoietic cell transplantation (HCT) is the only curative therapy for
myelofibrosis (MF). In this large multicenter retrospective study, overall survival (OS) in MF …
myelofibrosis (MF). In this large multicenter retrospective study, overall survival (OS) in MF …
Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT
DP McLornan, R Szydlo, M Robin… - British journal of …, 2018 - Wiley Online Library
Summary Allogeneic Haematopoietic Stem Cell Transplant (allo‐HSCT) remains the only
curative approach for Myelofibrosis (MF). Scarce information exists in the literature on the …
curative approach for Myelofibrosis (MF). Scarce information exists in the literature on the …
Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM‐TC)
M Robin, R Tabrizi, M Mohty, S Furst… - British journal of …, 2011 - Wiley Online Library
Allogeneic haematopoietic stem‐cell transplantation (HSCT) is the only curative treatment
for myelofibrosis. We report an analysis of the Société Française de Greffe de Moelle et de …
for myelofibrosis. We report an analysis of the Société Française de Greffe de Moelle et de …
Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International …
New options for medical therapy and risk scoring systems containing molecular data are
leading to increased complexity in the management of patients with myelofibrosis. To inform …
leading to increased complexity in the management of patients with myelofibrosis. To inform …
[HTML][HTML] Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
M Robin, LC De Wreede, C Wolschke, J Schetelig… - …, 2019 - ncbi.nlm.nih.gov
Allogeneic hematopoietic stem cell transplant remains the only curative treatment for
myelofibrosis. Most post-transplantation events occur during the first two years and hence …
myelofibrosis. Most post-transplantation events occur during the first two years and hence …
2021 update on allogeneic hematopoietic stem cell transplant for myelofibrosis: a review of current data and applications on risk stratification and management
H Ali, A Bacigalupo - American Journal of Hematology, 2021 - Wiley Online Library
The number of patients with myelofibrosis (MF) undergoing an allogeneic hemopoietic stem
cell transplantation (HSCT) is increasing: in the analysis of the European Group for Blood …
cell transplantation (HSCT) is increasing: in the analysis of the European Group for Blood …
[HTML][HTML] Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic …
M Ditschkowski, AH Elmaagacli, R Trenschel… - …, 2012 - ncbi.nlm.nih.gov
Background Myelofibrosis is a myeloproliferative stem cell disorder curable exclusively by
allogeneic hematopoietic stem cell transplantation and is associated with substantial …
allogeneic hematopoietic stem cell transplantation and is associated with substantial …
Outcome of allogeneic stem cell transplantation in patients with myelofibrosis
M Ditschkowski, DW Beelen, R Trenschel… - Bone marrow …, 2004 - nature.com
Myelofibrosis, either de novo or following pre-existing hematologic diseases, can be cured
by allogeneic hematopoietic stem cell transplantation (SCT), but SCT is associated with …
by allogeneic hematopoietic stem cell transplantation (SCT), but SCT is associated with …